Patents by Inventor Michael Kinnick

Michael Kinnick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel mch receptor antagonists
    Publication number: 20070135485
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: or a pharmaceutically acceptable salt thereof, useful for the treamtment useful fog treating Type H diabetes and/or obesity.
    Type: Application
    Filed: October 21, 2004
    Publication date: June 14, 2007
    Inventors: James Gillig, Michael Kinnick, John Morin, Antonio Navarro Martinez
  • Novel mch receptor antagonists
    Publication number: 20060052449
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar1, Ar2, Ar3, L1, L2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.
    Type: Application
    Filed: December 3, 2003
    Publication date: March 9, 2006
    Inventors: James Gillig, Lawrence Heinz, Michael Kinnick, Yen-Shi Lai, John Morin, Nancy Snyder
  • Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
    Publication number: 20050272718
    Abstract: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
    Type: Application
    Filed: May 6, 2003
    Publication date: December 8, 2005
    Inventors: Jochen Ammenn, James Gillig, Lawrence Heinz, Philip Hipskind, Michael Kinnick, Yen-Shi Lai, John Morin, James Nixon, Carsten Ott, Kenneth Savin, Theo Schotten, Lawrence Slieker, Nancy Snyder, Michael Robertson
  • Cyclopenta'b! indole derivatives as spla inhibitors
    Publication number: 20050026988
    Abstract: A novel class of tricyclic compounds of the following formula (I) is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.
    Type: Application
    Filed: July 29, 2002
    Publication date: February 3, 2005
    Inventors: Michael Kinnick, Edward Mihelich, John Morin, Daniel Sall, Jason Sawyer